Emster Kurt von - 12 Oct 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Director
Signature: By: /s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol: JSPR
Transactions as of: 12 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 13 Oct 2022, 20:05:32 UTC
Previous filing: 23 Mar 2022
Next filing: 27 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JSPR	Voting Common Stock	Award	$0	+30,250		$0.000000	30,250	12 Oct 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units (the "RSU Award"), 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Remarks:

The Reporting Person is no longer deemed to share an indirect pecuniary interest in the securities held by Abingworth Bioventures VII, LP, and therefore no longer reports those securities on his Section 16 reports.